The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT01260584

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01260584
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01260584. Randomized; triple masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2012-12-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
Intervention (Drug)
Prasugrel
Intervention (Drug)
Clopidogrel
Lead sponsor
Daiichi Sankyo (class: industry)

Record details

Record id
cardio:ct-nct01260584
Content hash
7abbc656cc6c75b81857cf0908759ed8d2356ffa7f0110e78c543c9b7b1b3660